Category 1B substances are presumed to have carcinogenic potential for humans. Therefore under COSHH there is a duty on employers to reduce exposure to such substances to as low a level as is reasonably practicable.
Menarini has completed its first 2017 Surgical Specimen Symposium seminar at the Regent Conference and events centre in London on Thursday 2nd February.
The seminar focused on the latest technologies and processes developed to minimise exposure to formalin, control fixation of surgical specimens and thus enabling optimal diagnostic reporting. The innovative solutions, TissueSAFE and SealSAFE enable full chain-of-custody specimen tracking starting in theatres. It also allows fixation to be brought under the control of the histology laboratory, making it a real science for optimal diagnostic results. Menarini also presented the brand new systems for Frozen Tissue Management, PrestoCHILL, FlashFREEZE and PRESTO. They day finished with demonstrations of the equipment which is always a highlight of our seminars!
Read more: Menarini's Seminar Series: Surgical Specimen Management
Menarini Diagnostics has made a significant investment in a new demonstration and training suite which has been opened in our UK headquarters at Winnersh Triangle business park, near Reading just off J10 of the M4. “This is a fantastic opportunity to present the full Total Tissue Diagnostics range in one place. We are looking forward to welcoming customers to the office and to being able to demonstrate the full capabilities of our product range.
Read more: New demonstration suite opened at Menarini UK headquarters.
